Extendicare (TSE:EXE – Free Report) had its price objective upped by BMO Capital Markets from C$11.00 to C$13.50 in a research note issued to investors on Monday morning,BayStreet.CA reports.
A number of other equities analysts have also weighed in on EXE. Cormark upgraded Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. TD Securities boosted their price objective on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada raised their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research note on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of C$11.50.
View Our Latest Analysis on Extendicare
Extendicare Stock Up 1.6 %
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 17th will be issued a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.67%. The ex-dividend date is Friday, February 28th. Extendicare’s payout ratio is currently 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- Trading Halts Explained
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What is the Dow Jones Industrial Average (DJIA)?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.